VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,284,000 | +6.8% | 83,866 | 0.0% | 0.92% | +0.9% |
Q2 2020 | $3,076,000 | +59.2% | 83,866 | 0.0% | 0.91% | +30.0% |
Q1 2020 | $1,932,000 | -21.3% | 83,866 | 0.0% | 0.70% | -8.4% |
Q4 2019 | $2,456,000 | +9.6% | 83,866 | 0.0% | 0.76% | +4.5% |
Q3 2019 | $2,240,000 | +4.5% | 83,866 | 0.0% | 0.73% | +5.5% |
Q2 2019 | $2,144,000 | +14.0% | 83,866 | 0.0% | 0.69% | -3.9% |
Q1 2019 | $1,880,000 | +6.3% | 83,866 | 0.0% | 0.72% | -3.1% |
Q4 2018 | $1,769,000 | +13.9% | 83,866 | 0.0% | 0.74% | +28.7% |
Q3 2018 | $1,553,000 | -17.0% | 83,866 | 0.0% | 0.58% | -18.6% |
Q2 2018 | $1,871,000 | +1.5% | 83,866 | 0.0% | 0.71% | -35.5% |
Q1 2018 | $1,843,000 | -5.4% | 83,866 | 0.0% | 1.10% | -13.6% |
Q4 2017 | $1,949,000 | – | 83,866 | – | 1.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |